APSR2026-1053

 
Late-Breaking
Submitted
Poster Presentation
 
AP02-026
P34
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1245594-46904-提出用_433760.pdf
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
2

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Hiroaki Ota * Iizuka Hospital Department of Respiratory Medicine Iizuka Japan
Kazunori Tobino - Iizuka Hospital Department of Respiratory Medicine Iizuka Japan
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Hiroaki
Ota
realflvna@gmail.com
+819048945345
31-40
Japan
Original Research
Clinical outcomes of pulmonary Mycobacterium avium complex disease diagnosed by bronchoscopy or repeated positive sputum cultures
Maximum 25 words
Abstract Content
Pulmonary Mycobacterium avium complex disease (MAC-PD) is diagnosed by either at least two positive sputum cultures or one positive bronchoscopic specimen, but whether the diagnostic method affects subsequent clinical course remains unclear. Because treatment indications for MAC-PD are not firmly established, understanding how diagnostic pathways relate to clinical decision-making is important. We compared time to treatment initiation or radiographic worsening, and reasons for treatment initiation, between patients diagnosed by repeated sputum cultures and those diagnosed by bronchoscopy.
This single-centre retrospective study included 80 patients diagnosed with MAC-PD between 2019 and 2023. Patients were classified into the sputum group (n=46) or bronchoscopy group (n=34). Patients with one positive sputum culture plus a positive bronchoscopic specimen were included in the bronchoscopy group. The primary outcome was time to the composite endpoint of treatment initiation or radiographic worsening, defined as new pulmonary opacities on follow-up imaging. Kaplan-Meier analysis and the log-rank test were performed.
The causative species were Mycobacterium avium (n=43) and Mycobacterium intracellulare (n=37). The composite endpoint occurred in 25/46 (54.3%) sputum-group patients and 24/34 (70.6%) bronchoscopy-group patients, with no significant difference (log-rank p=0.34). Smear positivity was more frequently cited as a reason for treatment in the sputum group (32.6% versus 5.9%; p=0.005), whereas radiographic worsening was more frequent in the bronchoscopy group (41.2% versus 21.7%; p=0.084). Cavitation was cited more often in the sputum group (32.6% versus 17.6%; p=0.199).
The diagnostic method was not significantly associated with clinical outcomes. However, treatment initiation appeared to follow different pathways, suggesting that diagnostic method may reflect baseline disease phenotype rather than prognosis alone. Larger studies are needed.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
pulmonary Mycobacterium avium complex disease, diagnostic method, treatment indication
maximum 3 keywords and no abbreviations, separated by commas
 
285